13 hrs ago
St. Jude Medical Stock Rating Reaffirmed by Goldman Sachs
's stock had its "neutral" rating reaffirmed by research analysts at Goldman Sachs in a report released on Monday, AnalystRatingsNetwork.com reports.
Fri May 17, 2013
StockCall Scrutinizes STJ, HOLX, NAVB, EW, and RMD
StockCall.com Provides Stock Research on St. Jude Medical Inc., Hologic Inc., Navidea Biopharmaceuticals Inc., Edwards Lifesciences Corp., and ResMed Inc.
Thu May 16, 2013
South Coast chorale offers concerts this weekend
The chorale will be performing selections from grand opera choruses, followed by selections from "The Wizard of Oz," "The Wiz," "Wicked" and other popular songs from the days of MGM and Cole Porter.
Tue May 14, 2013
Cath Lab Digest
St. Jude Medical Announces First Patient Enrollment in EnligHTN III...
St. Jude Medical, Inc. announced enrollment of the first patient in the EnligHTN III trial.
Sat May 11, 2013
St. Jude Medical Stock Rating Reaffirmed by Barclays Capital
's stock had its "overweight" rating reaffirmed by Barclays Capital in a research note issued on Thursday, Analyst Ratings.Net reports.
Fri May 10, 2013
Lead Situation Improves For St. Jude, But The Future Could Be Wireless
After years of safety worries about heart pacing leads, the sun could be appearing through the clouds for St.
St. Jude Gets FDA Green Light for Ellipse, Assura High Voltage Cardiac Devices
St. Jude Medical won FDA clearance for its Ellipse and Assura lines of implantable cardiac devices.
Billions In Renal Denervation: Medtronic, St Jude
Renal denervation therapy is a new, minimally invasive procedure that will help people with hopelessly high blood pressure that just refuses to budge to medication.
Thu May 09, 2013
The Motley Fool
Today's 3 Best Stocks
Today, the economic data was good, but apparently not good enough to sustain the market from its first down day in a week.
St. Jude Medical's Neutral Rating Reaffirmed at Zacks
's stock had its "neutral" rating restated by Zacks in a report issued on Thursday, Stock Ratings Network.com reports.
The Washington Post
St. Jude's Durata Lead Shown to Be Safe in Independent Analysis
St. Jude Medical Inc.'s Durata lead, the wire used to connect life-saving defibrillators to the heart, proved safe and reliable in an independent review that should ease concerns about its use, researchers said.
Wed May 08, 2013
Global Atherectomy and Thrombectomy Devices Market 2012-2016
The Global Atherectomy and Thrombectomy Devices market has also been witnessing an increase in patent grants and US FDA approvals.
The Washington Post
Nanostim's Wireless Pacemaker Shows Promise in First Patients
Nanostim Inc.'s miniaturized pacemaker, a device the size of a AAA battery placed entirely in the heart, appeared promising in its first human trials.
Mon May 06, 2013
St. Jude Medical Gets Too Much Praise
Every once in a while I am amazed at how some companies apparently can do no wrong, despite a constant stream of negative news.
Sun May 05, 2013
St. James's Place plc's Buy Rating Reaffirmed at Oriel Securities Ltd
's stock had its "buy" rating restated by equities researchers at Oriel Securities Ltd in a report issued on Wednesday, Stock Ratings Network reports.
Sat May 04, 2013
St. Jude Medical Receives Market Perform Rating from BMO Capital Markets
's stock had its "market perform" rating restated by analysts at BMO Capital Markets in a research report issued to clients and investors on Friday, Stock Ratings Network reports.
Thu May 02, 2013
St. Jude Medical Enrolls First Patient in Next-Generation Quadra Study
TM Pacing clinical study to build upon its first- to-market Quadripolar Pacing System.
Daily Dividend Report: HAR, STX, STJ, PRGO, RDS.A
This morning, Harman International declared its quarterly dividend of 15 cents per share, maintaining the amount paid to shareholders last quarter.
Wed May 01, 2013
St. Jude Medical (STJ) Plans Quarterly Dividend of $0.25
St. Jude Medical declared a quarterly dividend on Wednesday, May 1st, AnalystRatingsNetwork reports.